natgillin/translations-raw huggingface dataset:
(1R,2S,5R)-menthyl (2R,5S)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-1,3-oxathiolane-2-carboxylate
(1R,2S,5R)-mentil (2R,5S)-5-(4-amino-2-okso-1,2-dihidropirimidin-1-il)-1,3-oksatiolan-2-karboksilat
(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol 7,7-dioxide
(4S,6S)-5,6-dihidro-6-metil-4H-tieno[2,3-b]tiopiran-4-ol 7,7-dioksid
(1R,2S,5R)-menthyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate
(1R,2S,5R)-mentil(2R,5R)-5-hidroksi-1,3-oksatiolan-2-karboksilat
(2S)-N-[(R)-1-(1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2-4-[(4-methylpiperazin-1-yl)carbonyl]phenoxy-4-oxoazetidine-1-carboxamide
(2S)-N-[(R)-1-(1,3-benzodioksol-5-il)butil]-3,3-dietil-2-4-[(4-metilpiperazin-1-il)karbonil]fenoksi-4-oksoazetidin-1-karboksamid
(3aS,8aR)-3-[(2R,4S)-2-benzyl-4,5-epoxyvaleryl]-2,2-dimethyl-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazole
(3aS,8aR)-3-[(2R,4S)-2-benzil-4,5-eposkivaleril]-2,2-dimetil-3,3a,8,8a-tetrahidro-2H-indeno[1,2-d]oksazol
(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-2-fluoro-5-methyltetrahydrofuran-3,4-diyl diacetate
(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oksopirimidin-1(2H)-il)-2-fluoro-5-metiltetrahidrofuran-3,4-diil diacetat
(3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(3S)-10-[1-(acetilamino)ciklopropil]-9-fluoro-3-metil-7-okso-2,3-dihidro-7H-[1,4]oksazino[2,3,4-ij]kinolin-6-karboksilna kiselina
(2R,3S)-2-(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy-3-(4-fluorophenyl)morpholine hydrochloride
(2R,3S)-2-(1R)-1-[3,5-bis(trifluorometil)fenil]etoksi-3-(4-fluorofenil) morfolin hidroklorid
(3R)-3-(methoxymethyl)-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro[1,3]oxazolo[3,4-a]quinolin-1-one
(3R)-3-(metoksimetil)-7-(4,4,4-trifluorobutoksi)-3,3a,4,5-tetrahidro[1,3]oksazolo[3,4-a]kinolin-1-on
(5aR,11bS)-9,10-dimethoxy-2-propyl-4,5,5a,6,7,11b-hexahydrobenzo[f]thieno[2,3-c]quinoline hydrochloride
(5aR,11bS)-9,10-dimetoksi-2-propil-4,5,5a,6,7,11b-heksahidrobenzo[f]tieno[2,3-c]kinolin hidroklorid
(5S)-5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzoxazol-3-yl]-1,3-oxazolidin-2-one
(5S)-5-(metoksimetil)-3-[6-(4,4,4-trifluorobutoksi)-1,2-benzoksazol-3-il]-1,3-oksazolidin-2-on
(3S,10R,13Z,16S)-10-(3-chloro-4-methoxybenzyl)-3-isobutyl-6,6-dimethyl-16-[(1S)-1-((2R,3R)-3-phenyloxiran-2-yl)ethyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone
(3S,10R,13Z,16S)-10-(3-kloro-4-metoksibenzil)-3-izobutil-6,6-dimetil-16-[(1S)-1-((2R,3R)-3-feniloksiran-2-il)etil]-1,4-dioksa-8,11-diazacikloheksadek-13-en-2,5,9,12-tetron
(6S)-5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]thiophene-2-carboxylic acid
(6S)-5-[2-(2-amino-4-okso-4,6,7,8-tetrahidro-3H-pirimido[5,4-b][1,4]tiazin-6-il)etil]tiofen-2-karboksilna kiselina
(4S)-3-[(5R)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
(4S)-3-[(5R)-5-(4-fluorofenil)-5-hidroksipentanoil]-4-fenil-1,3-oksazolidin-2-on
((5S)-3-tert-butyl-2-phenyl-1,3-oxazolidin-5-yl)methanol
((5S)-3-terc-butil-2-fenil-1,3-oksazolidin-5-il)metanol
(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-3-(ethoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidinium (2S)-hydroxy(phenyl)acetate
(2R,3R,4S)-4-(1,3-benzodioksol-5-il)-3-(etoksikarbonil)-2-(4-metoksifenil)pirolidin(2S)-hidroksi(fenil)acetat
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine]
(2R)-3′H-spiro[4-azabiciklo[2.2.2]oktan-2,2′-furo[2,3-b]piridin]
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine] (S,S)-2,3-dihydroxybutanedioate
(2R)-3′H-spiro[4-azabiciklo[2.2.2]oktan-2,2′-furo[2,3-b]piridin] (S,S)-2,3-dihidroksibutandioat
(5R)-5-ethyl-5-hydroxy-1,4,5,8-tetrahydrooxepino[3,4-c]pyridine-3,9-dione
(5R)-5-etil-5-hidroksi-1,4,5,8-tetrahidrooksepino[3,4-c]piridin-3,9-dion
(1R)-5-(1,3,6,2-dioxazaborocan-2-yl)-1-methyl-2-tritylisoindoline
(1R)-5-(1,3,6,2-dioksazaborokan-2-il)-1-metil-2-tritilizoindolin
(3S)-1-[1-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yldiphenylacetonitrile
(3S)-1-[1-(2,3-dihidro-1-benzofuran-5-il)etil]pirolidin-3-ildifenilacetonitril
(2S)-hydroxy(phenyl)acetic acid-(1S)-3-(dimethylamino)-1-(2-thienyl)propan-1-ol (1:1) (salt)
(2S)-hidroksi(fenil)octena kiselina-(1S)-3-(dimetilamino)-1-(2-tienil)propan-1-ol (1:1) (sol)
(2R)-4-benzyl-2-(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxymorpholin-3-one
(2R)-4-benzil-2-(1R)-1-[3,5-bis(trifluorometil)fenil]etoksimorfolin-3-on
(5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
(5R)-5-(2,2-dimetil-4H-1,3-benzodioksin-6-il)-1,3-oksazolidin-2-on
(5R)-3-(6-2-[(2,6-dichlorobenzyl)oxy]ethoxyhexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
(5R)-3-(6-2-[(2,6-diklorobenzil)oksi]etoksiheksil)-5-(2,2-dimetil-4H-1,3-benzodioksin-6-il)-1,3-oksazolidin-2-on
(2S)-1-N-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]glycylpyrrolidine-2-carbonitrile
(2S)-1-N-[2-(5-metil-2-fenil-1,3-oksazol-4-il)etil]glicilpirolidin-2-karbonitril
(1R)-1,2-anhydro-4-C-(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol
(1R)-1,2-anhidro-4-C-(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-karboksilato-4-cikloheptilpiperazin-2-il)-6,9-dihidroksi-2,6-dimetil-11-oksooksaciklododek-3-en-1-il]penta-1,3-dien-1-il-3,5-dideoksi-1-[(2R,3S)-3-hidroksipentan-2-il]-D-eritropentitol
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine succinate
(2S)-2-[(S)-(2-etoksifenoksi)fenilmetil]morfolin sukcinat
(2Z)-3-(methylamino)-1-(2-thienyl)prop-2-en-1-one
(2Z)-3-(metilamino)-1-(2-tienil)prop-2-en-1-on
(2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-[(2-methylpropanoyl)oxy]methyltetrahydrofuran-3,4-diyl bis(2-methylpropanoate) hydrochloride
(2R,3S,4R)-5-(4-amino-2-oksopirimidin-1(2H)-il)-2-azido-2-[(2-metilpropanoil)oksi]metiltetrahidrofuran-3,4-diil bis(2-metilpropanoat) hidroklorid
(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-ylmethyl 3-chlorobenzoate
(2R,3S,4R,5R)-2-azido-5-(2,4-diokso-3,4-dihidropirimidin-1(2H)-il)-3,4-bis[(fenilkarbonil)oksi]tetrahidrofuran-2-ilmetil 3-klorobenzoat
(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one
(6R)-6-ciklopentil-6-[2-(2,6-dietilpiridin-4-il)etil]-3-[(5,7-dimetil[1,2,4]triazolo[1,5-a]pirimidin-2-il)metil]-4-hidroksi-5,6-dihidro-2H-piran-2-on
(2R)-3-(benzylsulfanyl)-N-[(2S)-1-[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-[(4-methylphenyl)sulfonyl]aminopropanamide
(2R)-3-(benzilsulfanil)-N-[(2S)-1-[(2S,3S)-1-hidrazinil-3-metil-1-oksopentan-2-il]amino-3-(4-hidroksifenil)-1-oksopropan-2-il]-2-[(4-metilfenil)sulfonil]aminopropanamid
(3S)-tetrahydrofuran-3-yl N-[(2S,3R)-3-hydroxy-4-(N-isobutyl-4-nitrobenzene-1-sulfonamido)-1-phenylbutan-2-yl]carbamate
(3S)-tetrahidrofuran-3-il N-[(2S,3R)-3-hidroksi-4-(N-izobutil-4-nitrobenzen-1-sulfonamido)-1-fenilbutan-2-il]karbamat
(3S)-2,2-dimethyl-4-[4-(4-pyridyloxy)phenylsulfonyl]-1,4-thiazinane-3-carboxylic acid
(3S)-2,2-dimetil-4-[4-(4-piridiloksi)fenilsulfonil]-1,4-tiazinan-3-karboksilna kiselina
(4R,6S)-6-((E)-2-4-(4-fluorophenyl)-6-isopropyl-2-[mesyl(methyl)amino]pyrimidin-5-ylvinyl)-2,2-dimethyl-1,3-dioxan-4-yl 3,3-dimethylbutanoate
(4R,6S)-6-((E)-2-4-(4-fluorofenil)-6-izopropil-2-[mezil(metil)amino]pirimidin-5-ilvinil)-2,2-dimetil-1,3-dioksan-4-il 3,3-dimetilbutanoat
(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium 4-methylbenzenesulfonate
(1R,2R)-1-[(ciklopropilsulfonil)karbamoil]-2-etilciklopropanaminij 4-metilbenzensulfonat
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol or apomorphine
(6aR)-6-metil-5,6,6a,7-tetrahidro-4H-dibenzo[de,g]kinolin-10,11-diol ili apomorfin
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(4S)-4-etil-4-hidroksi-1H-pirano[3′,4′:6,7]indolizino[1,2-b]kinolin-3,14(4H,12H)-dion
(5R)-9-chloro-5-ethyl-5-hydroxy-10-methyl-12-[(4-methylpiperidin-1-yl)methyl]-1,4,5,13-tetrahydro-3H,15H-oxepino[3′,4′:6,7]indolizino[1,2-b]quinoline-3,15-dione hydrochloride
(5R)-9-kloro-5-etil-5-hidroksi-10-metil-12-[(4-metilpiperidin-1-il)metil]-1,4,5,13-tetrahidro-3H,15H-oksepino[3′,4′:6,7]indolizino[1,2-b]kinolin-3,15-dion hidroklorid
(5S,5aS,9S)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 2,3-di-O-benzyl-4,6-O-[(1R)-ethylidene]-β-D-glucopyranoside
(5S,5aS,9S)-9-(4-hidroksi-3,5-dimetoksifenil)-8-okso-5,5a,6,8,8a,9-heksahidrofuro[3′,4′:6,7]nafto[2,3-d][1,3]dioksol-5-il 2,3-di-O-benzil-4,6-O-[(1R)-etiliden]-β-D-glukopiranozid
(6R,7R)-7-(N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonylamino)-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-(N-[(4-etil-2,3-dioksopiperazin-1-il)karbonil]-D-treonilamino)-3-[(1-metil-1H-tetrazol-5-il)sulfanil]metil-8-okso-5-tia-1-azabiciklo[4.2.0]okt-2-en-2-karboksilna kiselina
(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol, toluene solution
(2S,3R)-4-(dimetilamino)-3-metil-1,2-difenilbutan-2-ol, toluenova otopina
(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethan-1-ol, acetonitrile solution
(1R)-1-[3,5-bis(trifluorometil)fenil]etan-1-ol, acetonitrilova otopina
(3S)-3-[2-(mesyloxy)ethoxy]-4-(trityloxy)butyl methanesulfonate, dimethylformamide solution
(3S)-3-[2-(meziloksi)etoksi]-4-(tritiloksi)butil metansulfonat, dimetilformamidova otopina
Chemical name or description
Kemijski naziv ili naziv
Iron oxide containing not less than 50 % of Fe2O3 by weight.
Željezov oksid s masenim udjelom Fe2O3 ne manjim od 50 %.
fresh table grapes of heading ex0806,
svježe stolno grožđe iz tarifnog broja ex0806,
tobacco of heading ex2401,
duhan iz tarifnog broja ex2401,
nitrate of headings ex3102 and 3105.
nitrat iz tarifnih brojeva ex3102 i 3105.
List of bodies which may endorse certificates [143] [143]CN code ex
Popis tijela koja smiju ovjeriti potvrde [143] [143]Oznaka KN ex
CN code / TARIC code
KN oznaka/TARIC oznaka
Aromatic rice
mirisna riža
Basmati rice
basmati riža
Of the varieties Basmati 370, Basmati 386 (India), Type-3 (Dehradun India), Taraori Basmati (HBC-19 India), Basmati 217 (India), Ranbir Basmati (India), Kernel (Basmati Pakistan), Pusa Basmati, Super Basmati
sorti Basmati 370, Basmati 386 (Indija), Tip-3 (Dehradun Indija), Taraori Basmati (HBC-19 Indija), Basmati 217 (Indija), Ranbir Basmati (Indija), Kernel (Basmati Pakistan), Pusa Basmati, Super Basmati
In immediate packings of a net content not exceeding 5 kg
u neposrednim pakiranjima neto-mase ne veće od 5 kg
In immediate packings of a net content exceeding 5 kg but not exceeding 20 kg
u neposrednim pakiranjima neto-mase veće od 5 kg, ali ne veće od 20 kg
Extra virgin olive oil
ekstra djevičansko maslinovo ulje
In containers holding 5 litres or less
u spremnicima zapremnine do 5 l
Entry under this subheading is subject to the conditions laid down in the relevant provisions of the European Union (see Article 254 of Regulation (EU) No 952/2013 of the European Parliament and of the Council (OJ L 269, 10.10.2013, p. 1)).
Uvrštavanje u ovaj podbroj ovisi o uvjetima utvrđenima u odgovarajućim propisima Europske unije (vidjeti članak 254. Uredbe (EU) br. 952/2013 Europskog parlamenta i Vijeća (SL L 269, 10.10.2013., str. 1.)).
Entry under this subheading is subject to the presentation of a certificate of authenticity issued in accordance with the conditions laid down in Commission Regulation (EEC) No 139/81 (OJ L 15, 17.1.1981, p. 4).
Uvrštavanje u ovaj podbroj ovisi o predočenju potvrde o ispravnosti izdane sukladno uvjetima utvrđenima u Uredbi Komisije (EEZ-a) br. 139/81 (SL L 15, 17.1.1981., str. 4.).
‘Free’ for uses other than for use as a power or heating fuel, subject to the conditions laid down in the relevant provisions of the European Union (see Article 254 of Regulation (EU) No 952/2013 of the European Parliament and of the Council ( OJ L 269, 10.10.2013, p. 1)).
„Slobodno” za uporabu različitu od goriva ili goriva za grijanje, ovisi o uvjetima utvrđenima u odgovarajućim propisima Europske unije (vidjeti članak 254. Uredbe (EU) br. 952/2013 Europskog parlamenta i Vijeća (SL L 269, 10.10.2013., str. 1.)).
Entry under this subheading is subject to the conditions laid down in the relevant provisions of the European Union (see Article 4 of Commission Regulation (EC) No 2535/2001 (OJ L 341, 22.12.2001, p. 29); see also Article 254 of Regulation (EU) No 952/2013 of the European Parliament and of the Council (OJ L 269, 10.10.2013, p. 1).
Uvrštavanje u ovaj podbroj ovisi o uvjetima utvrđenima u odgovarajućim propisima Europske unije (vidjeti članak 4. Uredbe Komisije (EEZ) br. 2535/2001 (SL L 341, 22.12.2001., str. 29.); članak 254. Uredbe (EU) br. 952/2013 Europskog parlamenta i Vijeća (SL L 269, 10.10.2013., str. 1.)).
Straw (corresponds to the quantity needed for an insemination).
Pajeta (odgovara količini koja je potrebna za osjemenjivanje).
From 1 January to 31 March: 10,4 MIN 1,3 €/100 kg/br,from 1 April to 30 November: 12 MIN 2 €/100 kg/br,from 1 to 31 December: 10,4 MIN 1,3 €/100 kg/br.
Od 1. siječnja do 31. ožujka: 10,4 MIN 1,3 €/100 kg/br,od 1. travnja do 30. studenoga: 12 MIN 2 €/100 kg/br,od 1. do 31. prosinca: 10,4 MIN 1,3 €/100 kg/br.
Requirement not valid for virgin lampante oil (subheading 15091010) or for crude olive-residue oil (subheading 15100010).
Uvjet koji ne vrijedi za djevičansko lampantno ulje (podbroj 15091010) ili za sirovo maslinovo ostatno ulje (podbroj 15100010).
This suspension is subject to compliance with the formalities and conditions laid down in the relevant provisions of the European Union (see Article 254 of Regulation (EU) No 952/2013 of the European Parliament and of the Council (OJ L 269, 10.10.2013, p. 1)).
Ova privremena obustava ovisi o ispunjavanju formalnosti i uvjeta iz odgovarajućih propisa Europske unije (vidjeti članak 254. Uredbe (EU) br. 952/2013 Europskog parlamenta i Vijeća (SL L 269, 10.10.2013., str. 1.)).
Customs duty autonomously suspended, for an indefinite period, for ‘aircraft ground maintenance simulators, for civil use’ (TARIC code 9023008010).Entry under this subheading is subject to the conditions laid down in the relevant provisions of the European Union (see Article 254 of Regulation (EU) No 952/2013 of the European Parliament and of the Council (OJ L 269, 10.10.2013, p. 1)).
Carina autonomno obustavljena, na neograničeno razdoblje, za „simulatore održavanja zrakoplova na tlu, za civilnu uporabu” (oznaka TARIC 9023008010).Uvrštavanje u ovaj podbroj ovisi o uvjetima utvrđenima u odgovarajućim propisima Europske unije (vidjeti članak 254. Uredbe (EU) br. 952/2013 Europskog parlamenta i Vijeća (SL L 269, 10.10.2013., str. 1.)).
This suspension of customs duty is subject to the conditions laid down in the relevant provisions of the European Union being met (see Article 254 of Regulation (EU) No 952/2013 of the European Parliament and of the Council (OJ L 269, 10.10.2013, p. 1)).
Ta obustava carine ovisi o uvjetima utvrđenima u odgovarajućim propisima Europske unije (vidjeti članak 254. Uredbe (EU) br. 952/2013 Europskog parlamenta i Vijeća (SL L 269, 10.10.2013., str. 1.)).
Of an actual alcoholic strength by volume exceeding 15 % vol but not exceeding 18 % vol: 18,6 €/hl.Of an actual alcoholic strength by volume exceeding 18 % vol but not exceeding 22 % vol: 20,9 €/hl.Of an actual alcoholic strength by volume exceeding 22 % vol: 1,75 €/% vol/hl.
S volumnim udjelom alkohola većim od 15 vol. % ali ne većim od 18 vol. %: 18,6 €/hl.S volumnim udjelom alkohola većim od 18 vol. % ali ne većim od 22 vol. %: 20,9 €/hl.S volumnim udjelom stvarnog alkohola većim od 22 vol. %: 1,75 €/% vol/hl.
Of an actual alcoholic strength by volume exceeding 15 % vol but not exceeding 18 % vol: 14,8 €/hl.Of an actual alcoholic strength by volume exceeding 18 % vol but not exceeding 22 % vol: 15,8 €/hl.Of an actual alcoholic strength by volume exceeding 22 % vol: 1,75 €/% vol/hl.
S volumnim udjelom alkohola većim od 15 vol. % ali ne većim od 18 vol. %: 14,8 €/hl.S volumnim udjelom alkohola većim od 18 vol. % ali ne većim od 22 vol. %: 15,8 €/hl.S volumnim udjelom stvarnog alkohola većim od 22 vol. %: 1,75 €/% vol/hl.
Of an actual alcoholic strength by volume exceeding 15 % vol but not exceeding 18 % vol: 15,4 €/hl.Of an actual alcoholic strength by volume exceeding 18 % vol but not exceeding 22 % vol: 20,9 €/hl.Of an actual alcoholic strength by volume exceeding 22 % vol: 1,75 €/% vol/hl.
S volumnim udjelom alkohola većim od 15 vol. % ali ne većim od 18 vol. %: 15,4 €/hl.S volumnim udjelom alkohola većim od 18 vol. % ali ne većim od 22 vol. %: 20,9 €/hl.S volumnim udjelom stvarnog alkohola većim od 22 vol. %: 1,75 €/% vol/hl.
Of an actual alcoholic strength by volume exceeding 15 % vol but not exceeding 18 % vol: 12,1 €/hl.Of an actual alcoholic strength by volume exceeding 18 % vol but not exceeding 22 % vol: 13,1 €/hl.Of an actual alcoholic strength by volume exceeding 22 % vol: 1,75 €/% vol/hl.
S volumnim udjelom alkohola većim od 15 vol. % ali ne većim od 18 vol. %: 12,1 €/hl.S volumnim udjelom alkohola većim od 18 vol. % ali ne većim od 22 vol. %: 13,1 €/hl.S volumnim udjelom stvarnog alkohola većim od 22 vol. %: 1,75 €/% vol/hl.
from 1 July to 31 December: 3,3.
od 1. srpnja do 31. prosinca: 3,3.
from 1 July to 31 December: 3.
od 1. srpnja do 31. prosinca: 3.
from 1 July to 31 December: 1,8.
od 1. srpnja do 31. prosinca: 1,8.
from 1 July to 31 December: 1.
od 1. srpnja do 31. prosinca: 1.
from 1 July to 31 December: 1,1.
od 1. srpnja do 31. prosinca: 1,1.
from 1 July to 31 December: 1,7.
od 1. srpnja do 31. prosinca: 1,7.
from 1 July to 31 December: 1,9.
od 1. srpnja do 31. prosinca: 1,9.
from 1 July to 31 December: 1,4.
od 1. srpnja do 31. prosinca: 1,4.
from 1 July to 31 December: 1,3.
od 1. srpnja do 31. prosinca: 1,3.
from 1 July to 31 December: 2,3.
od 1. srpnja do 31. prosinca: 2,3.
from 1 July to 31 December: 1,5.
od 1. srpnja do 31. prosinca: 1,5.
from 1 July to 31 December: 4,5.
od 1. srpnja do 31. prosinca: 4,5.
from 1 July to 31 December: 4,8.
od 1. srpnja do 31. prosinca: 4,8.
from 1 July to 31 December: 4.
od 1. srpnja do 31. prosinca: 4.
from 1 July to 31 December: 10,4.
od 1. srpnja do 31. prosinca: 10,4.
from 1 July to 31 December: 2.
od 1. srpnja do 31. prosinca: 2.
from 1 July to 31 December: 7.
od 1. srpnja do 31. prosinca: 7.
from 1 July to 31 December: 5.
od 1. srpnja do 31. prosinca: 5.
from 1 July to 31 December: 6.
od 1. srpnja do 31. prosinca: 6.
from 1 July to 31 December: 10,5.
od 1. srpnja do 31. prosinca: 10,5.
from 1 July to 31 December: 7,5.
od 1. srpnja do 31. prosinca: 7,5.
from 1 July to 31 December: 9.
od 1. srpnja do 31. prosinca: 9.
from 1 July to 31 December: 2,5.
od 1. srpnja do 31. prosinca: 2,5.
from 1 July to 31 December: 3,8.
od 1. srpnja do 31. prosinca: 3,8.
from 1 July to 31 December: 1,2.
od 1. srpnja do 31. prosinca: 1,2.
from 1 July to 31 December: 2,1.
od 1. srpnja do 31. prosinca: 2,1.
from 1 July to 31 December: 3,4.
od 1. srpnja do 31. prosinca: 3,4.
from 1 July to 31 December: 2,4.
od 1. srpnja do 31. prosinca: 2,4.
from 1 July to 31 December: 1,6.
od 1. srpnja do 31. prosinca: 1,6.
1024 bits
1024 bita
1048576 bits
1048576 bita
(6Z,9Z,12Z)-octadeca-6,9,12-trienoate (INNCN)
(6Z,9Z,12Z)-oktodeka-6,9,12-trienoat (INNCN)
21A-glycine-30Bα-L-arginine-30Bβ-L-arginine (INNCN)
21A-glicin-30Bα-L-arginin-30Bβ-L-arginin (INNCN) glikolat hidroksiacetat glioksilat oksoacetat
hydroxynaphtoate (INNRG)
etilpentanoat izonikotinat
iodide (INNRG)
jodid (INNRG)
(3aR,4R,5R,6aS)-5-hydroxy-4-((3R)-3-hydroxy-5-phenylpentyl)hexahydrocyclopenta[b]furan-2-one
(3aR,4R,5R,6aS)-5-hidroksi-4-((3R)-3-hidroksi-5-fenilpentil)heksahidrociklopenta[b]furan-2-on
(2E)-but-2-enedioate
(2E)-but-2-enedioat
hibenzate (INNRG)
hidrogen sukcinat hidrogen butandioat (INNCN) hibenzat (INNRG) hibenzat
hybenzate
4-(4-hidroksibenzoil)benzoat (INNCN) hidrat hidrobromid hidroklorid hidroksibenzoat
hydrobromide
hipurat
2-(4-hydroxybenzoyl)benzoate
isetionat, 2-hidroksietansulfonat 2-hidroksietan-1-sulfonat (INNCN) izobutirat 2-metilpropanoat izoftalat
o-(4-hydroxybenzoyl)benzoate
benzen-1,3-dikarboksilat izokaproat
hydroxynaphthoate
piridin-4-karboksilat izopropil
(2R,3R)-2,3-dihydroxybutanedioate (INNCN), L-tartarate
(2R,3R)-2,3-dihidroksibutandioat (INNCN), L-tartarat
(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl (INNCN)
(2E,6E)-3,7,11-trimetildodeka-2,6,10-trien-1-il (INNCN)
3B-L-lysine,29B-L-glutamic acid (INNCN) glutamer (INNRG)
3B-L-lizin,29B-L-glutaminska kiselina (INNCN)
Wilkings
wilking mandarine
(2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexanedioate, D-glucarate gluceptate (INNRG)
(2R,3S,4S,5S)-2,3,4,5-tetrahidroksiheksandioat, D-glukarat
28B-L-aspartic acid- (INNCN) aspartate
28B-L-aspartinska kiselina- (INNCN)
ethanol – hydrogen chloride – water (0,5/1/0,5) (INNCN) hydrate
etanol – klorovodik – voda (0,5/1/0,5) (INNCN)
hydrochloride hydrogen
N-benzoilglicinska sol
‘Silicon based sensors’ consist of microelectronic or mechanical structures that are created in the mass or on the surface of a semiconductor and that have the function of detecting physical or chemical quantities and transducing these into electric signals, caused by resulting variations in electric properties or displacement of a mechanical structure. ‘Physical or chemical quantities’ relates to real world phenomena, such as pressure, acoustic waves, acceleration, vibration, movement, orientation, strain, magnetic field strength, electric field strength, light, radioactivity, humidity, flow, chemicals concentration, etc.
„senzori s osnovnim materijalom od silicija” sastoje se od mikroelektroničkih ili mehaničkih struktura koje su oformljene u masi ili na površini poluvodiča i koji imaju funkciju otkrivanja fizikalnih i kemijskih količina i njihovog pretvaranja u električne signale, uslijed promjena koje proizlaze iz električnih svojstava ili pomicanja mehaničke strukture; „fizikalne ili kemijske količine” odnosi se na pojave stvarnog svijeta, kao što su tlak, zvučni valovi, ubrzanje, vibracije, pokret, orijentacija, naprezanje, jakost magnetskog polja, jakost električnog polja, svjetlost, radioaktivnost, vlaga, protok, koncentracija kemikalija itd.
hydroxide hydroxybenzoate
isetionat (INNRG)
xopentanoate lisetil (INNRG)
ksopentanoat
lisicol (INNRG) N-[(5S)-5-carboxy-5-(3α,7α,12α-trihydroxy-5β-cholan-24-amido)pentyl]carbamothioylamino (INNCN)
L-lizinat (ester), dietil (ester)(INNCN)
Commission Regulation (EU) 2016/1822
Uredba Komisije (EU) 2016/1822
amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, deltamethrin, fluazinam, methomyl, sulcotrione and thiodicarb in or on certain products
o izmjeni priloga II., III. i V. Uredbi (EZ) br. 396/2005 Europskog parlamenta i Vijeća u pogledu maksimalnih razina ostataka za aklonifen, deltametrin, fluazinam, metomil, sulkotrion i tiodikarb u ili na određenim proizvodima
For aclonifen, fluazinam and sulcotrione, maximum residue levels (MRLs) were set in Part A of Annex III to Regulation (EC) No 396/2005.
Maksimalne razine ostataka (MRO) za aklonifen, fluazinam i sulkotrion utvrđene su u dijelu A Priloga III. Uredbi (EZ) br. 396/2005.
For deltamethrin, methomyl and thiodicarb, maximum residue levels (MRLs) were set in Annex II and Part B of Annex III to Regulation (EC) No 396/2005.
Maksimalne razine ostataka (MRO) za deltametrin, metomil i tiodikarb utvrđene su u Prilogu II. i dijelu B Priloga III. Uredbi (EZ) br. 396/2005.
For aclonifen, the European Food Safety Authority, hereinafter ‘the Authority’, submitted a reasoned opinion on the existing MRLs in accordance with Article 12(1) of Regulation (EC) No 396/2005 [2].
Europska agencija za sigurnost hrane (dalje u tekstu: „Agencija”) dostavila je za aklonifen obrazloženo mišljenje o postojećim MRO-ovima u skladu s člankom 12. stavkom 1. Uredbe (EZ) br. 396/2005 [2].